Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mallinckrodt Plc (MNK)

Mallinckrodt Plc (MNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 223,464
  • Shares Outstanding, K 84,009
  • Annual Sales, $ 3,216 M
  • Annual Income, $ -3,607,000 K
  • 60-Month Beta 2.48
  • Price/Sales 0.07
  • Price/Cash Flow 0.14
  • Price/Book 0.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 2.01
  • Number of Estimates 8
  • High Estimate 2.09
  • Low Estimate 1.90
  • Prior Year 2.10
  • Growth Rate Est. (year over year) -4.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.98 +34.34%
on 10/15/19
2.97 -10.44%
on 09/23/19
+0.13 (+5.14%)
since 09/18/19
3-Month
1.43 +86.01%
on 09/05/19
7.25 -63.31%
on 07/19/19
-4.56 (-63.16%)
since 07/18/19
52-Week
1.43 +86.01%
on 09/05/19
32.34 -91.77%
on 11/13/18
-24.54 (-90.22%)
since 10/18/18

Most Recent Stories

More News
Is the Options Market Predicting a Spike in Mallinckrodt (MNK) Stock?

Investors need to pay close attention to Mallinckrodt (MNK) stock based on the movements in the options market lately.

MNK : 2.66 (+4.31%)
Watch for Mallinckrodt to Potentially Pullback After Gaining 13.23% Yesterday

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $2.25 to a high of $2.44. Yesterday, the shares gained 13.2%, which took the trading range above the 3-day high of $2.37...

MNK : 2.66 (+4.31%)
SmarTrend Watching for Potential Rebound in Shares of Mallinckrodt After 4.90% Loss

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $2.29 to a high of $2.55. Yesterday, the shares fell 4.9%, which took the trading range below the 3-day low of $2.38 on...

MNK : 2.66 (+4.31%)
Mallinckrodt to Report Earnings Results for Third Quarter 2019

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that it will report third quarter 2019 earnings results for the period ended Sept. 27, 2019 on Tuesday, Nov. 5, 2019.

MNK : 2.66 (+4.31%)
J&J Settles Ahead of Multi-District Opioid Trial, Stock Up

J&J (JNJ) reaches settlement agreement with Cuyahoga and Summit counties in Ohio concerning the lawsuits pending in MDL.

JNJ : 127.70 (-6.22%)
AGN : 173.60 (+0.64%)
ENDP : 4.88 (+0.93%)
MNK : 2.66 (+4.31%)
Mallinckrodt Up on Settlement Agreement With Ohio Counties

Mallinckrodt (MNK) gains on the execution of a settlement agreement with Cuyahoga and Summit Counties in Ohio concerning the lawsuits pending in MDL.

JNJ : 127.70 (-6.22%)
ENDP : 4.88 (+0.93%)
MNK : 2.66 (+4.31%)
TEVA : 7.50 (-3.47%)
Mallinckrodt Announces Positive Top-Line Findings from its Observational Registry Assessing Relapse Recovery in Multiple Sclerosis Relapse Patients Treated with Acthar® Gel (Repository Corticotropin Injection)

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced positive top-line findings from its observational registry to assess treatment patterns and response to Acthar® Gel (repository...

MNK : 2.66 (+4.31%)
Mallinckrodt Finalizes Settlement to Resolve "Track 1" Opioid Cases with the Ohio Counties of Cuyahoga and Summit

Mallinckrodt plc (NYSE: MNK), along with its wholly owned subsidiaries Mallinckrodt LLC and SpecGx LLC, today announced that it has executed a definitive settlement agreement and release (the "Settlement...

MNK : 2.66 (+4.31%)
MALLINCKRODT DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm

New York, New York--(Newsfile Corp. - September 24, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Mallinckrodt plc (NYSE: MNK) ("Mallinckrodt" or the "Company") ...

MNK : 2.66 (+4.31%)
Mallinckrodt's StrataGraft Tissue Phase III Data Positive

Mallinckrodt's (MNK) experimental StrataGraft regenerative tissue meets goals in a late-stage study for the treatment of burns.

JNJ : 127.70 (-6.22%)
ENDP : 4.88 (+0.93%)
TEVA : 7.50 (-3.47%)
MNK : 2.66 (+4.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade MNK with:

Business Summary

Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media...

See More

Key Turning Points

2nd Resistance Point 2.83
1st Resistance Point 2.74
Last Price 2.66
1st Support Level 2.53
2nd Support Level 2.41

See More

52-Week High 32.34
Fibonacci 61.8% 20.53
Fibonacci 50% 16.89
Fibonacci 38.2% 13.24
Last Price 2.66
52-Week Low 1.43

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar